The Ohio State University is at the forefront of biomedical technology and multidisciplinary research, in large part due to the depth and breadth of resources available on campus for basic and clinical scientists. By sharing these esoteric resources, the University can exploit economies of scale, decrease dependency on outside resources and increase opportunities for collaboration. The Ohio State University Research Foundation (OSURF), led by Executive Director Robert Killoren, promotes development, implementation and coordination of sponsored research at Ohio State by overseeing sponsored projects and personnel associated with them, including financial resources, equipment inventory and compliance issues. The Technology Licensing and Commercialization (TLC) team, led by Jean Schelhorn, PhD, oversees protection of intellectual property via patent, copyright and/or trademark, marketing University technologies, negotiating license agreements, consulting about intellectual property on sponsored research projects, and ensuring compliance with federal regulations related to intellectual property. University Laboratory Animal Resources, led by DirectorWilliam Yonushonis, is a centralized program that supports the humane, legal, proper and scientifically valid use of animals in scientific research at Ohio State. Biosafety Level 3 Facilities are located on Ohio State’s main and west campuses. A Biosafety Level 3 Facility is located in the Biomedical Research Tower to safely handle potentially infectious agents with the intent to guarantee biocontainment of pathogens under study. Campus Chemical Instrument Center (CCIC), was founded in 1981 as a unit of The Ohio State University Office of Research. Under the direction of Ming-Daw Tsai, PhD, the center focuses on providing state-of-the-art research facilities for the entire campus in three areas: nuclear magnetic resonance, mass spectrometry and proteomics. Chemistry-Mass Spectrometry Facility, a CCICrelated unit, is able to analyze small organic molecules using either positive ion electrospray ionization or electron impact ionization analysis. Chemistry NMR (Nuclear Magnetic Resonance) Laboratory, managed by Karl Vermillion, provides access to four Bruker NMR spectrometers. Plant-Microbe Genomics Facility serves the entire campus, as well as researchers in the state of Ohio and beyond, by providing resources to study genomes – from DNA sequence to protein expression. Microscopic and Chemical Analysis Research Center (MARC) is a University wide instrument service laboratory that supports research through elemental chemical analysis capabilities ranging from nanometer scale microscopic imaging to bulk chemical composition. Bio Medical Mass Spectrometry Facility, directed by Kenneth Chan, PhD, performs pharmacoanalytical services and assists investigators in solving pharmacoanalytical problems. Based at the College of Pharmacy. Center for Materials Research, led by David Rigney, PhD, CMR associate director and professor of Materials Science and Engineering, promotes interdisciplinary scholarship among faculty, facilitates industrial partnerships, encourages interdisciplinary undergraduate and graduate education, provides a mechanism for major cooperative research funding, and creates central multi user research facilities for the study of familiar and new materials. Ohio Supercomputer Center (OSC). Under executive director Stanley Ahalt, PhD, the OSC provides a high-performance computing and communications infrastructure for a diverse statewide community, including members of educational, academic research, industry and state government institutions. In collaboration with this community, OSC evaluates, implements and supports new and emerging information. Within OSC, the Biomedical Applications Research Group involves an interdisciplinary group of research and computer scientists and clinicians whose goals include applying high-performance computing to biomedicine and applying advanced interface technology for virtual exploration of complex computational data. Don Stredney, research scientist and director, interface lab, is also a member of the Experimental Therapeutics Program at the OSUCCC. |
